Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
- Sector - Healthcare
- Equity
- Very High Risk
Rating:
Key Metrics
Aum
₹1,073.85 Cr
Expense Ratio
1.90%
Exit Load
1.00%
Min. Investment
₹1,000.00
Min. SIP
₹100.00
Launch Date
11 Jul 2019
CAGR Returns
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | -1.41% | -- |
| 3 Months | +8.71% | -- |
| 6 Months | +15.67% | -- |
| 1 Year | +15.93% | +15.93% |
| 2 Years | -- | +6.42% |
| 3 Years | +73.53% | +20.17% |
| 5 Years | +83.16% | +12.87% |
| Since Launch | +261.39% | +19.62% |
Holdings as on 14 Sep 2026
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Torrent Pharmaceuticals | 106.69 | 9.94 |
| Sun Pharmaceutical Industries | 104.72 | 9.75 |
| Apollo Hospitals Enterprise | 76.08 | 7.08 |
| Cipla | 48.93 | 4.56 |
| Aurobindo Pharma | 46.03 | 4.29 |
| Ajanta Pharma | 44.81 | 4.17 |
| Sai Life Sciences | 41.73 | 3.89 |
| Mankind Pharma | 38.43 | 3.58 |
| Lupin | 37.73 | 3.51 |
| Abbott India | 35.96 | 3.35 |
Morning Star Rating
Rating:
Risk
Return
Risk & Volitility
0.95
Sharpe Ratio
15.26%
Std. Deviation
--
Tracking Error
--
Alpha
--
Beta
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | +15.37% | +22.91% | +15.03% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth | +15.93% | +20.17% | +12.87% |
| Tata India Pharma & Healthcare Fund Regular Growth | +7.09% | +17.94% | +12.93% |
| WhiteOak Capital Pharma and Healthcare Fund Regular Growth | +20.61% | -- | -- |
| Kotak Healthcare Fund Regular Growth | +26.06% | -- | -- |
Results are calculated on CAGR basis
About Fund
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
The Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has an AUM of 1073.85 crores & has delivered CAGR of 12.87 in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.90%. The minimum investment in Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is Rs 1000 and the minimum SIP is Rs 100.
As per morningstar the risk & return rating of the fund are Moderate & Exceptional respectively.
The fund has a present cash holding of %. The top holdings of the fund include Torrent Pharmaceuticals, Sun Pharmaceutical Industries, Apollo Hospitals Enterprise, Cipla.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs, Investment Services.
Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, Tata India Pharma & Healthcare Fund Regular Growth, WhiteOak Capital Pharma and Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth. Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.95 & a standard deviation of 15.26%.
FAQs
According to the morning star rating Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has a Moderate risk & Exceptional return.
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is managed by Dhaval Shah.
The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is 1.90%.
The 5 year annualized return on Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is 12.87% & it has generated 15.93% in the last 1 year.
The minimum investment in Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth is 1000 Rs.
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth has an AUM of 1073.85 crores.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.